NRC Health NRC
NASDAQ
| 09/30/2026 | 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | |
|---|---|---|---|---|---|
| Revenue | 143.79M | 140.00M | 138.64M | 137.39M | 139.10M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 143.79M | 140.00M | 138.64M | 137.39M | 139.10M |
| Cost of Revenue | 56.52M | 53.55M | 52.96M | 52.37M | 52.79M |
| Gross Profit | 87.27M | 86.45M | 85.68M | 85.02M | 86.32M |
| SG&A Expenses | 53.04M | 53.27M | 44.57M | 41.51M | 44.95M |
| Depreciation & Amortization | 8.50M | 8.63M | 8.25M | 7.62M | 7.00M |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 118.07M | 115.44M | 105.78M | 101.51M | 104.73M |
| Operating Income | 25.72M | 24.55M | 32.86M | 35.89M | 34.37M |
| Income Before Tax | 10.51M | 9.38M | 14.50M | 17.85M | 23.45M |
| Income Tax Expenses | 4.07M | 3.53M | 5.47M | 6.25M | 7.09M |
| Earnings from Continuing Operations | 6.44 | 5.86 | 9.04 | 11.60 | 16.36 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 6.44M | 5.86M | 9.04M | 11.60M | 16.36M |
| EBIT | 25.72M | 24.55M | 32.86M | 35.89M | 34.37M |
| EBITDA | 34.23M | 33.18M | 41.11M | 43.51M | 41.37M |
| EPS Basic | 0.29 | 0.25 | 0.39 | 0.50 | 0.70 |
| Normalized Basic EPS | 0.58 | 0.55 | 0.79 | 0.87 | 0.83 |
| EPS Diluted | 0.27 | 0.24 | 0.38 | 0.49 | 0.70 |
| Normalized Diluted EPS | 0.58 | 0.55 | 0.79 | 0.87 | 0.83 |
| Average Basic Shares Outstanding | 87.32M | 87.72M | 88.37M | 89.55M | 91.11M |
| Average Diluted Shares Outstanding | 87.61M | 87.86M | 88.51M | 89.57M | 91.13M |
| Dividend Per Share | 0.64 | 0.60 | 0.56 | 0.52 | 0.48 |
| Payout Ratio | 209.16% | 216.85% | 130.95% | 94.63% | 67.82% |